Equillium (EQ)

• Market cap: $193M
• 1 day: 10.91%
• 5 days: 11.31%
• 1 month: 65.76%
• 3 months: 41.86%
• 6 months: 177.27%
• Year to date: 99.35%
• 1 year: 824.24%
• 5 years: -48.74%
• 10 years: -78.21%
• Sector: Healthcare
• Industry: Biotechnology

About: Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Employees: 14